It was reported that embelin rapidly inactivates PCAF activity and has a strong apoptosis-inducing effect on leukemia cell lines and on prostate and pancreatic cancer cells through the inhibition of DNA binding [49]. The gene discussed is KAT2B; the disease is pancreatic neoplasm.